☆ 4.6 Editorial Material

Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the question

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Endocrinology & Metabolism

Overview of the 2022 WHO Classification of Pituitary Tumors

Sylvia L. Asa et al.

Summary: This review summarizes the changes in the 5th Edition of the WHO Classification of Endocrine and Neuroendocrine Tumors related to the pituitary gland, including the classification of pituitary lobe tumors and the detailed subtyping based on tumor cell lineage, cell type, and characteristics.

ENDOCRINE PATHOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients

Federica Guaraldi et al.

Summary: Genetic mutations and DNA methylation levels of genes involved in cell proliferation/differentiation, miRNA/LncRNA-post-transcriptional regulators, and therapy targets vary between non-aggressive and aggressive PAs/PitNETs. Methylation profiles also differ according to gender. Combined genetic-epigenetic analysis, along with clinical-radiological-pathological data, could aid in predicting the behavior of PA/PitNET.

CLINICAL ENDOCRINOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients

Pia Burman et al.

Summary: This study describes the characteristics and treatment outcomes of aggressive pituitary tumors (APT) and pituitary carcinomas (PC). Temozolomide is the first-line chemotherapy, but other therapies are also emerging. Predicting treatment response remains challenging with current biomarkers.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Real-life clinical impact of a five-tiered classification of pituitary tumors

Nicolas Sahakian et al.

Summary: In this study, the prognostic value of the clinicopathological classification of pituitary tumors was examined in 607 patients. The study found that grading of the tumors predicted the risk of progression/recurrence, with invasive and proliferative tumors having a higher risk. Additionally, patients with proliferative tumors were more likely to require retreatment after primary surgery. Radiotherapy was effective in controlling tumor growth in cases of progression or recurrence.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

添加到收藏夹

Article Neurosciences

TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome

Luis Gustavo Perez-Rivas et al.

Summary: This study found that TP53 mutations are more common than expected in corticotroph macroadenomas, and these mutations are associated with larger and more invasive tumors that are difficult to manage.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

添加到收藏夹

Article Endocrinology & Metabolism

USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors

Andrew Uzilov et al.

Summary: This study found recurrent somatic mutations in USP8 and TP53 genes in corticotroph tumors, which were mutually exclusive and may be independent driver genes. USP8-WT tumors had extensive somatic copy number variation compared with USP8-mutated tumors. The findings suggest that corticotroph tumors can be categorized into a USP8-mutated, genome-stable subtype and a USP8-WT, genome-disrupted subtype with a TP53-mutated subtype.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

添加到收藏夹

Review Endocrinology & Metabolism

Aggressive pituitary tumours and pituitary carcinomas

Gerald Raverot et al.

Summary: Anterior pituitary tumors are usually benign but can exhibit aggressive behavior, potentially developing into pituitary carcinomas. Current treatment approaches primarily involve surgery or radiotherapy, with standard medical treatments often ineffective and the need for personalized use of emerging therapies for better outcomes.

NATURE REVIEWS ENDOCRINOLOGY (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations

Olivera Casar-Borota et al.

Summary: ATRX mutations are common in a subset of aggressive pituitary tumors, particularly in corticotroph tumors. Performing ATRX immunohistochemistry can help identify patients at risk of developing aggressive and potentially metastatic pituitary tumors.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

添加到收藏夹

Article Endocrinology & Metabolism

A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s

Federica Guaraldi et al.

CLINICAL ENDOCRINOLOGY (2020)

添加到收藏夹

Article Endocrinology & Metabolism

The epidemiology of aggressive pituitary tumors (and its challenges)

Olaf M. Dekkers et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions

Jacqueline Trouillas et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre

S. Asioli et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients

Julie Lelotte et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

添加到收藏夹

Article Endocrinology & Metabolism

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

Gerald Raverot et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

添加到收藏夹

Article Endocrinology & Metabolism

Aggressive pituitary tumours and carcinomas: two sides of the same coin?

Jacqueline Trouillas et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

添加到收藏夹

Article Endocrinology & Metabolism

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

Ann McCormack et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

添加到收藏夹

Article Endocrinology & Metabolism

Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification

Gerald Raverot et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

添加到收藏夹

Article Clinical Neurology

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up

Jacqueline Trouillas et al.

ACTA NEUROPATHOLOGICA (2013)

添加到收藏夹

Article Endocrinology & Metabolism

Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management

Ilyess Zemmoura et al.

PITUITARY (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.